The binding of MC4R to its endogenous ligand, α-melanocyte-stimulating hormone (α-MSH), has demonstrated the protective, anti-inflammatory, and anti-apoptotic effects in experimental renal ischemia/reperfusion, cerebral ischemia, and traumatic brain injury [14–16]. The gene discussed is MC4R; the disease is brain ischemia.